The words “sure-fire” and biotechnology stocks rarely go together. This is a sector of the stock market that carries ...

The biotech sector is one that’s become red-hot, at least in recent years. After around a decade of stagnation, investors ...

Summit Therapeutics has generated plenty of buzz in the biotech industry over the past two years. That's because the ...

Earlier on December 16, Canaccord Genuity recently lowered its price target for Tenaya Therapeutics to $4 from $6, while ...

Over the past few years, Axsome Therapeutics has made slow and steady clinical and regulatory progress. The company's lineup ...

The rise of China, the buzz around AI, challenging global market dynamics, the recent surge in dealmaking and exciting new ...

Biotech investors spent years waiting for the sector to recover from its brutal 2021 peak. That patience is finally paying ...

The volatile biotech industry has put up a strong performance in 2025 despite the uncertain macroeconomic environment. While the tariff saga hit the pharma/biotech industry earlier in the year, the ...

Triple-leveraged ETFs aren’t for everyone, but if you believe biotech is about to break out, Direxion Daily S&P Biotech Bull ...

In this article, we will examine the 15 Best Biotech Stocks to Buy According to Wall Street Analysts. The biotech sector has been a disaster for investors over the past five years going by a 14% ...